NASDAQ:LABT | News | Lakewood-Amedex Biotherapeutics Inc.

LABT News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-07-15Current reportSEC filingLakewood-Amedex Biotherapeutics Inc. filed Form 8-KLakewood-Amedex Biotherapeutics Inc. filed Form 8-K covering items 7.01,9.01.
2026-06-17Current reportSEC filingLakewood-Amedex Biotherapeutics Inc. filed Form 8-KLakewood-Amedex Biotherapeutics Inc. filed Form 8-K covering items 3.03,5.03,9.01.
2026-04-28Current reportSEC filingLakewood-Amedex Biotherapeutics Inc. filed Form 8-KLakewood-Amedex Biotherapeutics Inc. filed Form 8-K covering items 5.02,9.01.